| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
PRLD sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 6.48M | - | - | |
| 10% | 1.13M | $5.00M | - | |
| 10% | 1.13M | $5.00M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | Bonita David P64 | Director, 10% Owner | Buy | 2,815,315 | $4.44 | $12,499,998.60 | -166.7% | -12.1% | - | |
| Apr 21, 2026 | Orbimed Advisors LLC66 | Director, 10% Owner | Buy | 2,815,315 | $4.44 | $12,499,998.60 | -166.7% | -12.1% | - | |
| Mar 25, 2025 | Combs Andrew56 | Chief Chemistry Officer | Buy | 100,000 | $0.69 | $69,250.00 | +26.3% | +20.8% | +368.8% | |
| Mar 25, 2025 | Vaddi Krishna78 | CEO | Buy | 675,000 | $0.69 | $467,437.50 | +51.0% | +20.8% | +368.8% | |
| Mar 21, 2025 | Vaddi Krishna78 | CEO | Buy | 20,416 | $0.73 | $14,909.43 | +1.6% | +21.1% | +320.8% | |
| Mar 17, 2025 | Vaddi Krishna78 | CEO | Buy | 39,105 | $0.75 | $29,459.84 | +3.1% | +29.0% | +354.4% | |
| Mar 13, 2025 | Vaddi Krishna78 | CEO | Buy | 97,500 | $0.71 | $69,564.00 | +8.4% | +54.9% | +366.8% | |
| Dec 31, 2024 | Vaddi Krishna78 | CEO | Buy | 5,000 | $1.21 | $6,043.50 | +3.6% | -39.8% | +127.5% | |
| Dec 30, 2024 | Vaddi Krishna78 | CEO | Buy | 10,000 | $1.20 | $12,000.00 | +7.8% | -36.5% | +134.7% | |
| Dec 23, 2024 | Combs Andrew56 | Chief Chemistry Officer | Buy | 63,075 | $1.36 | $85,538.25 | +20.1% | -41.9% | +76.6% |